Long-Term Data Reinforce Givinostat Efficacy, Safety in DMD
Written by
American Journal Managed Care
Published
0
comments
0
min
Givinostat shows promise in delaying Duchenne muscular dystrophy (DMD) progression, enhancing mobility, and maintaining safety in long-term treatment.